Taking weight loss injections was linked to a 27 point jump in employment for unemployed women, new economic research finds. Here's what it means.
Taking weight loss injections may do more than shrink a waistline. New research suggests it could also improve a woman's odds of landing a job, pointing to an economic dimension of GLP-1 medications that hasn't gotten much attention until now.
At a Glance
- Unemployed women using GLP-1 drugs saw a 27 percentage point jump in employment after 18 months
- Marriage and cohabitation rates rose 29 percentage points over the same period
- About 6% of U.S. women had started a GLP-1 for weight loss by the end of 2024
- Uptake was higher, at 9%, among women with a history of obesity
- No evidence emerged that the drugs helped already employed women earn raises or promotions
What the Research Found
The findings come from Harvard economist Rebecca Diamond, in a paper published by the National Bureau of Economic Research. Diamond compared women who began a GLP-1 regimen to lose weight against women who wanted to use the drugs but had not yet started. The gap in outcomes between the two groups was substantial: those on the medication were far more likely to move from unemployment into a job within a year and a half.
The Female Obesity Penalty
Diamond's work builds on a well documented pattern researchers call the obesity penalty. Studies have shown that heavier women tend to earn less and receive fewer callbacks after initial job interviews compared with thinner peers. The penalty appears tied largely to first impressions rather than ongoing job performance. Diamond found that once a woman is already employed, starting a GLP-1 does not appear to change her career trajectory through raises or promotions. The effect shows up almost entirely at the hiring stage.
That distinction matters. It suggests the bias operates most strongly during interviews, when appearance shapes snap judgments, and fades once someone is established in a role where performance can speak for itself.
Why Weight Loss Might Change Job Prospects
Diamond considered whether the employment gains might simply reflect better physical health, since GLP-1 drugs are known to ease weight related health problems. But the numbers did not support that explanation on their own. Employment gains in her study population outpaced the reduction in reported work limitations, leading her to conclude that visible weight loss itself, rather than health improvements alone, drove most of the change. Most of the new hires came from the ranks of the unemployed, not from people returning to the workforce after retirement or disability.
Who Has Access
The paper also flags a concern about equity. Diamond notes that early adopters of GLP-1 drugs tend to be disproportionately financially advantaged, meaning the economic benefits she documents may not be evenly distributed. She used data from the Understanding America Study, a nationally representative survey of U.S. adults, to reach her conclusions. In her own words, unequal access to the drugs could determine who is able to sidestep the social and economic costs tied to body size, a possibility she describes as unsettling given that it turns a medical treatment into a workaround for discrimination.
What Happens as Access Widens
The central question left open by this research is what happens to the obesity penalty itself if GLP-1 use keeps spreading beyond wealthier early adopters. If access broadens, the employment gap Diamond measured could narrow across the board, or it could simply shift the advantage to whoever can afford treatment at any given time. Either way, the data adds a fresh angle to debates about who benefits from these drugs and why.
Frequently Asked Questions
How weight loss injections?
GLP-1 medications are typically self administered through a weekly injection, and they work alongside diet and lifestyle changes to support weight loss over time.
Why weight loss injections?
People use them primarily to lose weight and manage related health conditions, though this research points to added social and economic effects, including improved job prospects for previously unemployed women.
What weight loss injections?
GLP-1 receptor agonists are the main class of drugs involved, originally developed to treat diabetes before being adapted for weight management.
Is weight loss injections safe?
Health authorities generally consider approved GLP-1 medications safe when used under medical supervision, though like any medication they carry potential side effects that a doctor should discuss with each patient.
How weight loss injections work?
They work by mimicking a hormone that regulates appetite and blood sugar, which helps reduce hunger and slow digestion, leading to gradual weight loss.
This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting or stopping any medication.